BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Business

  DVS Sciences Appoints Joseph Victor as President and CEO

  December 5, 2011

   · 

  2 min read
• Genetown

  Cell Signaling Technology, Inc. Wins Life Science Industry Awards in “Best Performing Antibodies” and “Best Breakthrough Products Cancer Research” Categories

  December 5, 2011

   · 

  1 min read
• BioCapital

  Emergent BioSolutions Announces Acceptance of Four TRU-016 Abstracts for Presentation at 2011 American Society of Hematology Annual Meeting

  December 5, 2011

   · 

  1 min read
• Novo Nordisk A/S: Share Repurchase Program

  December 5, 2011

   · 

  1 min read
• Biotech Beach

  Avila Therapeutics to Present at the 2011American Society of Hematology Annual Meeting

  December 5, 2011

   · 

  1 min read
• Policy

  Amherst-Based Pharmaceutical Company, ONY, Inc., Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants

  December 5, 2011

   · 

  3 min read
• Genetown

  Cell Signaling Technology, Inc. Wins Life Science Industry Awards in “Best Performing Antibodies” and “Best Breakthrough Products Cancer Research” Categories

  December 5, 2011

   · 

  1 min read
• Business

  Radius Transitions Company Leadership; Names Michael Wyzga President and Chief Executive Officer to Advance Phase 3 Osteoporosis Drug and Drive Corporate Strategy

  December 5, 2011

   · 

  6 min read
• Business

  Hi-Tech Pharmacal Reports Sales of $56.9 Million and EPS INTERNATIONAL of $1.04 for the Second Quarter Ended October 31, 2011

  December 5, 2011

   · 

  1 min read
• Pharm Country

  NanoViricides, Inc. Announces That It Has Submitted a Pre-IND Meeting Request to the US FDA For Its Anti-Influenza Clinical Drug Candidate, FluCide™

  December 5, 2011

   · 

  1 min read